One of the principal functions of the Food and Drug Administration is to determine the safety and effectiveness of all regulated medical products before they are released for use by the public. Medications, diagnostic tests and medical devices such as pacemakers fall under FDA’s purview. From the outset FDA has had to contend with intense pressures from manufacturers and politicians to rush approvals. Twice in recent months the Trump administration has pushed the FDA to give emergency authorization for use of hydroxychloroquine and convalescent plasma for treatment of COVID-19.
Serious regulation of drugs began with the passage in 1906 of the Pure Food and Drug Act which set uniform standards and prohibited interstate transport of adulterated or mislabeled products. Multiple lawsuits limited the law’s effectiveness. Regulatory authority rested in the Division of Chemistry in the Department of Agriculture until the FDA was created in 1930. Today, FDA is an agency within the Department of Health and Human Services.
Following years of opposition by drug manufacturers, The Food, Drug, and Cosmetic Act of 1938 was enacted after a series of deaths from a toxic sulfa drug. The law required detailed review of all new drugs for safety and efficacy. Loopholes and continuing litigation interfered with enforcement of standards.
Tennessee Sen. Estes Kefauver led hearings from 1959 to 1962, which resulted in stronger authority for the FDA. The hearings got a boost in 1960, when a drug manufacturer led a concerted attack on Dr. Frances Kelsey, the new medical officer at FDA, for delaying approval for Thalidomide, a drug promoted for relief of nausea during pregnancy. The drug had been approved in Germany. Free, promotional samples had been sent to U.S. physicians. Kelsey was concerned by reports of birth defects related to thalidomide. She held firm for 18 months until proof of thalidomide’s toxic effect on fetuses was proved.
The next challenge for FDA occurred in the 1970s when 27 states sought to legalize sale of Laetrile, a drug promoted as a cure for cancer. Americans suffering from malignant diseases traveled to Mexico, where laetrile was legalized to receive treatment. Again, FDA prevailed after studies showed Laetrile had no benefit and had caused deaths in some patients.
